Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01164774 | Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions | PHASE1 | COMPLETED | 54 | — | — | Oct 1, 2005 | Nov 1, 2005 | Jul 19, 2010 | 1 | India |
| NCT01164761 | Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions | PHASE1 | COMPLETED | 54 | — | — | Sep 1, 2005 | Oct 1, 2005 | Jul 19, 2010 | 1 | India |
| Arm | Type | Description |
|---|---|---|
| Ramipril | EXPERIMENTAL | Ramipril 10 mg capsules of Dr. Reddy's Laboratories Limited |
| Altace | ACTIVE_COMPARATOR | Altace@ 10 mg capsules of Kings Pharmaceuticals, USA |
| Name | Type | Description |
|---|---|---|
| Ramipril | DRUG | Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited |
| Altace | DRUG | Altace@ 10 mg capsules of Kings Pharmaceuticals, USA |
Inclusion Criteria: 1. Healthy males between 18 and 45 years of age (both inclusive) living in and around Ahmedabad city of western part of India. 2. Having a Body Mass Index (BMI) between 18.5 and 24.9 (both inclusive), calculated as weight in kg/height in m2 3. Not having any significant diseases...